BON BON
Company Profile ↓Company Overview
BON (BON) is a publicly traded company listed on with a market capitalization of $8.54M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 0.2.
Carries low leverage with a debt-to-equity ratio of 0.21.
Recent Developments
- Sep 2025 Revenue of $18.67M (-21.7% YoY); net profit $-1.99M.
- Trailing 12 Months Year-on-year growth — revenue -21.7%, earnings -601.0%.
- 5-Year Trend Long-term compounding — revenue CAGR -14.5%, profit CAGR -44.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -14.54% |
| 1 Year: | -21.70% |
Compounded Profit Growth
| 5 Years: | -43.99% |
| 1 Year: | -600.98% |
Stock Price Performance
| 1 Year: | -18.60% |
| 6 Months: | -37.13% |
| 3 Months: | -17.71% |
| 1 Month: | -12.50% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)31.91 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -14.5% CAGR over 5 years.
- Earnings shrank at -44.0% CAGR over 5 years.
- Trading 54.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Revenue | - | 29.91M | 29.52M | 23.84M | 18.67M |
| Cost of Revenue | - | 20.48M | 20.68M | 16.73M | 14.79M |
| Gross Profit | - | 9.42M | 8.84M | 7.11M | 3.88M |
| Operating Expenses | - | 1.52M | 2.88M | 5.17M | 5.46M |
| Operating Income | - | 7.91M | 5.96M | 1.94M | -1.59M |
| EBITDA | - | 8.38M | 6.99M | 2.30M | -57.82K |
| Interest Expense | - | 446.82K | 238.17K | 303.25K | 366.18K |
| Pretax Income | - | 7.57M | 5.57M | 715.94K | -1.71M |
| Tax Provision | - | 1.27M | 1.00M | 351.18K | 339.41K |
| Net Income | - | 6.24M | 4.60M | 398.17K | -1.99M |
| Diluted EPS | 170.00 | 185.75 | 124.92 | 4.14 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 37.26M | 46.56M | 61.77M | 85.19M |
| Current Assets | - | 14.72M | 24.18M | 39.79M | 45.76M |
| Cash & Equivalents | - | 840.86K | 111.30K | 80.47K | 3.77M |
| Inventory | - | 1.72M | 987.29K | 1.57M | 3.31M |
| Receivables | - | 6.78M | 4.60M | 11.78M | 11.01M |
| Total Liabilities | - | 7.16M | 10.57M | 17.42M | 27.19M |
| Current Liabilities | - | 6.65M | 9.61M | 16.45M | 26.31M |
| Long Term Debt | - | 189.81K | 871.37K | 970.06K | 842.82K |
| Total Debt | - | 5.41M | 4.12M | 7.30M | 12.29M |
| Total Equity | - | 29.56M | 35.48M | 43.91M | 57.55M |
| Shares Outstanding | - | 33.58K | 46.95K | 158.82K | 8.13M |
Cash Flows (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -187.12K | -616.90K | -7.72M | 141.12K |
| Investing Cash Flow | - | -3.06M | -1.19M | -15.73K | -10.00M |
| Financing Cash Flow | - | 2.26M | 1.16M | 8.76M | 15.45M |
| Capital Expenditure | - | -2.07M | -731.10K | -7.05K | -10.00M |
| Free Cash Flow | - | -2.26M | -1.35M | -7.73M | -9.85M |
| Net Change in Cash | - | -981.26K | -647.32K | 1.02M | 5.60M |
Ratios (Annual)
Figures in %.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 31.5% | 29.9% | 29.8% | 20.8% |
| Operating Margin % | - | 26.4% | 20.2% | 8.1% | -8.5% |
| Net Margin % | - | 20.9% | 15.6% | 1.7% | -10.7% |
| ROE % | - | 21.1% | 13.0% | 0.9% | -3.5% |
| ROCE % | - | 25.8% | 16.1% | 4.3% | -2.7% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Xtx Topco Ltd | 0.26% | 15.90K | $16.69K |
| 2 | UBS Group AG | - | 46 | $48 |
| 3 | Caitong International Asset Management Co., Ltd | - | 7 | $7 |
| 4 | Osaic Holdings Inc. | - | 1 | $1 |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BON
BON|Bon Natural Life Ltd|Price:1.130|Chg%:+0.030 - TradingKey
<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTE94bFNZdlZub0FnNlJTRVUwc3lEMjRSdEgzMzRaaTRPNXEtU2VBVDJQd3g1YTZLdVlwYWx4OXR2RWtQRERpclB3a05HTk9jSFM5ZkZycU9GX0M?oc=5" target="_blank">BON|Bon Natural Life Ltd|Price:1.130|Chg%:+0.030…
Boiron SA Revenue Breakdown – MUN:BON - TradingView
<a href="https://news.google.com/rss/articles/CBMickFVX3lxTE14cGNUUTdUTjl5dUR5VkxtVmduVm8tZ1Jwa0pyUzZMNlhwdmVRcTRBa1YwX2F0Q19IS1dEQ1ZiQ3JTZmM4dXZQVkhicHJHS3lWZk9Oa1duenV0cmdYUkJ0NlU1NFBqRk5iTkNoa2I0bG9Wdw?oc=5" target="_blank">Boiron SA Rev…
Ready for a Wellness Reset? Stock Your Pantry With These Snacks, Drinks, and Supplements - Bon Appétit: Recipes, Cooking, Entertaining, Restaurants | Bon Appétit
<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1FSUtRMGxEZk9paWlaMnJmcjdBazZ2NWhqM011cHAxb1A5d3JHSUxfM3NOclVOWWxERVN3UGlpeXM0Ym9MT3dGT29pX2ZqV3N4Qk45eUtKZUNialhKUGlmeGNYYWpCZGJuVzZjWA?oc=5" target="_blank">Ready for a Wellness …
‘Cross Road’: When Bon Jovi Took Stock Of Their Greatness - udiscovermusic.com
<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxQc2dkZ2oza2t3YTRMTlctWGpwSzZ3VWp2c19aSnhyajNBM2lYaFlCV1hHaDZHbFlGNUtKVl9hTmdBTWpBc0dnWDBFVlVsc3pwVHhOTGpYQlNBWEdVNUV2TFhLNy1KR0FZWHEwNzQ4WWY1Nk1yem9Rai0yeVRHV29fVjNCZFVGQQ?oc=5" t…
BON Stock Hovers Near Support Amid Minimal Price Movement – Bon Natural Life Limited (BON) Analysis - Initial Balance - dars.gov.et
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxNamhleWZuU2NYc1BHSjAxM3FibkVITURqOC1pYXR4REEzdHpfcjk1TkQtQ0xIQUw1RHRxWlZkNlBoYnVmLXlKelBPSElvVW1Vd3AwNk5qc3hiYUVBcGExdGFqbDNaZFlNM0V3bkdTeGszNzdqRlo4WUJNQ0drRy14UktDQW44Q21PaGYtdU…
BON|Bon Natural Life Ltd|Price:1.100|Chg%:+0.010 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE9PMzNSdHRQZlp3Sk92RFZGeWZJSlNpYl9yTXlMcUpRUW9NWkZaLUU1R0pRaEloMm81RmRuUW5yVFRGdGNOWmZJVEJ3X25mREtoRXp3OGJfeVNVRWF3eUJXS1JDaTN1Z2JtSmdUUA?oc=5" target="_blank">BON|Bon Natural Life …
BON — Frequently Asked Questions
What is the current share price of BON?
As of 2026-08-05 17:25 PDT, BON trades at $1.05 on NASDAQ/NYSE. Its 52-week range is $1.05 to $2.28.
What is the market capitalisation of BON?
BON has a market capitalisation of $8.54M on NASDAQ/NYSE.
What is the P/E ratio of BON?
BON trades at a trailing price-to-earnings (P/E) ratio of 0.25. Its price-to-book (P/B) ratio is 0.15.
What is the return on equity (ROE) of BON?
BON has a return on equity (ROE) of -3.47%. Its return on capital employed (ROCE) is -2.28%.
Is BON a good stock to buy?
This page provides a data-driven analysis of BON, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.